ICARES Medicus, Inc. (TPEX: 6612)
Taiwan
· Delayed Price · Currency is TWD 126.00
+1.50 (1.20%)
Nov 21, 2024, 11:56 AM CST
ICARES Medicus Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 742.27 | 605.45 | 511.85 | 393.92 | 362.67 | 419.36 | Upgrade
|
| Revenue Growth (YoY) | 22.98% | 18.29% | 29.94% | 8.62% | -13.52% | 27.36% | Upgrade
|
| Cost of Revenue | 211.33 | 123.05 | 94.41 | 71.04 | 70.8 | 87.53 | Upgrade
|
| Gross Profit | 530.94 | 482.4 | 417.44 | 322.89 | 291.87 | 331.84 | Upgrade
|
| Selling, General & Admin | 255.65 | 186.31 | 157.23 | 127 | 116.32 | 122.58 | Upgrade
|
| Research & Development | 177.63 | 177.45 | 133.08 | 104.87 | 98.25 | 91.16 | Upgrade
|
| Operating Expenses | 440.43 | 373.84 | 292.73 | 235.03 | 213.36 | 226.29 | Upgrade
|
| Operating Income | 90.51 | 108.56 | 124.71 | 87.85 | 78.52 | 105.55 | Upgrade
|
| Interest Expense | -17.22 | -7.17 | -0.58 | -0.83 | -0.98 | -1.17 | Upgrade
|
| Interest & Investment Income | 31.07 | 5.29 | 2.67 | 2.48 | 1.5 | 3.66 | Upgrade
|
| Earnings From Equity Investments | 1.94 | -1.35 | -4.18 | -2.17 | -5.46 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -6.4 | 0.93 | 15.72 | -4.81 | -6.43 | -1.89 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.35 | 4.56 | 5.1 | 3.99 | 2.6 | 2.86 | Upgrade
|
| EBT Excluding Unusual Items | 113.24 | 110.82 | 143.44 | 86.51 | 69.74 | 109.02 | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.81 | 2.47 | -0.33 | -13.32 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 4.02 | -0.01 | Upgrade
|
| Pretax Income | 107.43 | 113.29 | 143.11 | 73.19 | 73.76 | 109.01 | Upgrade
|
| Income Tax Expense | 87.49 | 48.86 | 32.72 | 35.82 | 36.84 | 40.52 | Upgrade
|
| Earnings From Continuing Operations | 19.94 | 64.43 | 110.39 | 37.37 | 36.93 | 68.49 | Upgrade
|
| Minority Interest in Earnings | 46.14 | 33.3 | 18.52 | 21.23 | 14.98 | 12.53 | Upgrade
|
| Net Income | 66.08 | 97.73 | 128.91 | 58.6 | 51.91 | 81.02 | Upgrade
|
| Net Income to Common | 66.08 | 97.73 | 128.91 | 58.6 | 51.91 | 81.02 | Upgrade
|
| Net Income Growth | -48.13% | -24.19% | 119.97% | 12.90% | -35.93% | 15.00% | Upgrade
|
| Shares Outstanding (Basic) | 42 | 38 | 37 | 37 | 37 | 37 | Upgrade
|
| Shares Outstanding (Diluted) | 43 | 39 | 37 | 37 | 37 | 37 | Upgrade
|
| Shares Change (YoY) | 13.85% | 2.90% | 0.74% | 0.38% | 0.38% | 5.24% | Upgrade
|
| EPS (Basic) | 1.56 | 2.55 | 3.46 | 1.58 | 1.41 | 2.21 | Upgrade
|
| EPS (Diluted) | 1.55 | 2.54 | 3.45 | 1.58 | 1.40 | 2.20 | Upgrade
|
| EPS Growth | -54.40% | -26.39% | 117.82% | 12.99% | -36.36% | 9.50% | Upgrade
|
| Free Cash Flow | -162.16 | -96.74 | 97.47 | 33.18 | 62.26 | -4.63 | Upgrade
|
| Free Cash Flow Per Share | -3.80 | -2.51 | 2.61 | 0.89 | 1.68 | -0.13 | Upgrade
|
| Dividend Per Share | 0.182 | 0.182 | 0.909 | 0.455 | 0.091 | 0.455 | Upgrade
|
| Dividend Growth | -80.00% | -80.00% | 100.02% | 400.00% | -80.00% | 0% | Upgrade
|
| Gross Margin | 71.53% | 79.68% | 81.56% | 81.97% | 80.48% | 79.13% | Upgrade
|
| Operating Margin | 12.19% | 17.93% | 24.36% | 22.30% | 21.65% | 25.17% | Upgrade
|
| Profit Margin | 8.90% | 16.14% | 25.19% | 14.88% | 14.31% | 19.32% | Upgrade
|
| Free Cash Flow Margin | -21.85% | -15.98% | 19.04% | 8.42% | 17.17% | -1.11% | Upgrade
|
| EBITDA | 154.27 | 129.33 | 142.69 | 106.87 | 99.58 | 122.02 | Upgrade
|
| EBITDA Margin | 20.78% | 21.36% | 27.88% | 27.13% | 27.46% | 29.10% | Upgrade
|
| D&A For EBITDA | 63.76 | 20.77 | 17.97 | 19.02 | 21.07 | 16.47 | Upgrade
|
| EBIT | 90.51 | 108.56 | 124.71 | 87.85 | 78.52 | 105.55 | Upgrade
|
| EBIT Margin | 12.19% | 17.93% | 24.36% | 22.30% | 21.65% | 25.17% | Upgrade
|
| Effective Tax Rate | 81.44% | 43.13% | 22.86% | 48.94% | 49.94% | 37.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.